Risk of Acne in Patients With Atopic Dermatitis Starting a JAK Inhibitor vs Th2 Cytokine Inhibitor

JAMA Dermatology 2026 Open access

Read full text
Authors: Maria C. Schneeweiss, Richard Wyss, Priyanka Anand, Yinzhu Jin, Arash Mostaghimi, John S. Barbieri, Joseph F. Merola, Jonathan I. Silverberg, David Rosmarin, R GLYNN, Sebastian Schneeweiß
DOI: 10.1001/jamadermatol.2025.5443
Cited by: 5
References: 5

Abstract

This cohort study evaluates the risk of acne in adult patients with atopic dermatitis who started treatment with Janus kinase inhibitors compared with Th2 cytokine inhibitors.

Fields of Study & Subjects

Dermatology and Skin Diseases Acne and Rosacea Treatments and Effects Psoriasis: Treatment and Pathogenesis

Publication details

Journal / source
JAMA Dermatology
Publisher
American Medical Association (AMA)
Volume
162
Issue
3
Pages
313–313
Publication date
21 January 2026
Language
EN